Delivery Order SPE2DB20D3103-SPE2DB23FM0H1
Award Date 12/29/22
Potential Completion Date 12/30/22
Potential Value $5.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of hydroxychloroquine 200 mg tablets in 100-count bottles, with a ceiling value of $3,909.46 and a completion date of September 3, 2024. The contract is a firm fixed-price type and was not set aside for any specific business category. AmerisourceBergen holds a significant Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,632.85 delivery order contract is for the supply of hydroxychloroquine 200 mg tablets. The contract has a firm fixed price and a completion date of March 22, 2023. There is no set-aside designation for this award. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,557,932,255 tablets of Hydroxychloroquine 200 mg, a critical pharmaceutical product. The Firm Fixed Price contract has a ceiling value of $8,276.28 and a completion date of July 29, 2022. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- The Defense Logistics Agency awarded a delivery order valued at $2,341.23 to AmerisourceBergen Drug Corp for the supply of Hydroxychloroquine 200 mg tablets (100-count units) on November 25, 2025. This is a firm fixed price delivery order with an ultimate completion date of November 26, 2025, with performance to be executed at the awardee's facility in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's demonstrated...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 500 tablets of Hydroxychloroquine 200 mg, with a contract value of $2,780.34 and a firm fixed price structure. This non-competitive delivery order, issued on December 12, 2025, is due for completion by December 15, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement from the company's existing Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $5,151.91 to AmerisourceBergen Drug Corp for the supply of Hydroxychloroquine 200 mg tablets (500-count units). This contract, awarded on October 20, 2025, with an ultimate completion date of October 21, 2025, represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- This federal contract award, with an ID of SPE2DB20D3104|SPE2DB22FV6T9, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,829.34 firm fixed-price delivery order is for the supply of 4,557,140 units of hydroxychloroquine 200mg tablets. The contract has an ultimate completion date of May 9, 2022 and was awarded on May 6, 2022. This award is not designated as a set-aside contract....
- This federal contract award, with ID SPE2DB20D3103|SPE2DB23FL9X2, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,778.42 firm fixed-price delivery order is for the supply of 4,559,444,350 units of hydroxychloroquine 200 mg tablets. The award is not designated as a set-aside contract. It is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen Drug Corp...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,711.53 firm fixed-price contract is for the delivery of 100 tablets of the drug Plaquenil (hydroxychloroquine sulfate 200 mg) to Conshohocken, Pennsylvania. The contract has an ultimate completion date of July 11, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999.00...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $1,182.82 fixed-price contract is for the delivery of Plaquenil (hydroxychloroquine) 200 mg tablets to support federal healthcare programs. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...